HA
HC Advisors’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,504
| Closed | -$3.5M | – | 66 |
|
2024
Q1 | $3.5M | Hold |
4,504
| – | – | 1.67% | 15 |
|
2023
Q4 | $2.63M | Hold |
4,504
| – | – | 1.47% | 17 |
|
2023
Q3 | $2.42M | Sell |
4,504
-100
| -2% | -$53.7K | 1.44% | 18 |
|
2023
Q2 | $2.16M | Sell |
4,604
-109
| -2% | -$51.1K | 1.25% | 21 |
|
2023
Q1 | $1.62M | Buy |
4,713
+109
| +2% | +$37.4K | 1% | 24 |
|
2022
Q4 | $1.68M | Buy |
4,604
+100
| +2% | +$36.6K | 1.15% | 21 |
|
2022
Q3 | $1.46M | Hold |
4,504
| – | – | 1% | 25 |
|
2022
Q2 | $1.46M | Sell |
4,504
-363
| -7% | -$118K | 1.04% | 24 |
|
2022
Q1 | $1.39M | Hold |
4,867
| – | – | 0.88% | 30 |
|
2021
Q4 | $1.34M | Buy |
4,867
+4
| +0.1% | +$1.11K | 0.82% | 27 |
|
2021
Q3 | $1.12M | Buy |
4,863
+1,595
| +49% | +$369K | 0.74% | 26 |
|
2021
Q2 | $750K | Buy |
+3,268
| New | +$750K | 0.46% | 35 |
|
2020
Q3 | – | Sell |
-9,403
| Closed | -$1.54M | – | 82 |
|
2020
Q2 | $1.54M | Buy |
+9,403
| New | +$1.54M | 1.28% | 19 |
|
2020
Q1 | – | Sell |
-9,638
| Closed | -$1.27M | – | 45 |
|
2019
Q4 | $1.27M | Buy |
+9,638
| New | +$1.27M | 1.31% | 21 |
|